BTIG analyst Carl Reichardt maintains Lennar (NYSE:LEN) with a Buy and raises the price target from $104 to $116.
Bionano Announces Peer-Reviewed Publication On The Utility Of Combining OGM And A 523-Gene NGS Panel For Standard Evaluation Of Myeloid Cancers
Bionano Genomics, Inc. (BNGO), today announced the publication in Cancers of a peer-reviewed study from Augusta University on the utility of combining optical genome mapping (OGM) and a 523-gene